Cidara Therapeutics/$CDTX
About Cidara Therapeutics
Ticker
Industry
Employees
CDTX Metrics
$229M
-
-$23.94
0.98
-
Price and volume
Market cap
$229M
Beta
0.98
52-week high
$28.42
52-week low
$10.00
Average daily volume
94K
Financial strength
Current ratio
3.536
Quick ratio
2.911
Long term debt to equity
2.043
Total debt to equity
3.41
Management effectiveness
Return on assets (TTM)
-23.89%
Return on equity (TTM)
-200.46%
Valuation
Price to revenue (TTM)
2.363
Price to book
1.27
Price to tangible book (TTM)
1.27
Price to free cash flow (TTM)
-0.659
Growth
Revenue change (TTM)
44.48%
Earnings per share change (TTM)
168.65%
3-year revenue growth (CAGR)
-1.04%
3-year earnings per share growth (CAGR)
6.21%
What the Analysts think about CDTX
Analyst Ratings
CDTX Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
CDTX Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
CDTX News
FAQs
What’s the current market cap for Cidara Therapeutics stock?
What is the P/E ratio for Cidara Therapeutics stock?
Does Cidara Therapeutics stock pay dividends?
No, Cidara Therapeutics (CDTX) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Cidara Therapeutics dividend payment date?
Cidara Therapeutics (CDTX) stock does not pay dividends to its shareholders.
What is the beta indicator for Cidara Therapeutics?
Cidara Therapeutics (CDTX) has a beta rating of 0.98. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.